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Two peptides with tachykinin-like abitity to contract lon~tudinal muscle from the guinea pig ileum were 
isolated from the intestine of the common dogfish, Scyliorhinus canicutus. The amino acid sequence of seylio- 
rhinin I was established asAla-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH* and this peptide cross-reacted 
with antisera directed against the C-terminal region fo substance P. The amino acid sequence ofscyliorhinin 
II was established as Ser-Pro-Ser-Asn-Ser-Lys-Cys-Pro-Asp-Gly-Pro-Asp-Cys-Phe-Val-Gly-Leu-Met-NH~ 
and this peptide cross-reacted with antisera directed against the C-terminal region of neurokinin A. The 
mammalian peptides substance P and neurokinin A were absent from the dogfish intestinal tissue. 
Scyliorhinin (Dogfish) Substance P Neurokinin A Tachykinin 
1. I~RODU~ION 
The tachykinins are a family of polypeptides 
that share a common C-terminal sequence, repre- 
sented by Phe-X-Gly-Leu-Met-NH2 and a similar 
spectrum of biological activities. Physalaemin and 
upcrolein (X = Tyr), phy~omedusin (X = He) and 
kassinin (X = Val) were isolated from the skin of 
frogs and eledoisin (X = Ile) from a mollusc 
(review [l]). Recent studies have demonstrated that 
mammalian nervous tissue contains, in addition to 
substance P (X = Phe), neurokinin A (X = Val) 
[2] and ne~oki~n B (X = Val) 131. Here, pre- 
liminary investigations howed that extracts of the 
intestine of the common dogfish, Scyliorhinus 
caniculus, produced strong, dose-dependent con- 
tractions of longitudinal muscle from the guinea 
pig ileum, suggesting the possible presence of 
tachyki~n-relate peptides. By using regionally 
specific antisera raised against substance P and 
neurokinin A in radioimmunoassays [4,5], we have 
isolated from the extracts two novel tachykinins, 
termed scyliorhinin I and II. Sequence analysis has 
shown that the peptides show m~mum homology 
with the amphibian peptides, physalaemin and 
Glu’Pro’-kassinin [6]. 
2. MATERIALS AND METHODS 
2.1. Tissue extraction 
Intestinal tissue (204 g) from 4 adult dogfishes 
was homogenized at 4°C with 8 vols ethanol/O.7 M 
HCI (3 : 1, v/v) using a Waring blender. The homo- 
genate was stirred overnight at 4OC, centrifuged 
(1600x g, 1 h) and the ethanol removed from the 
su~mat~t under reduced pressure. After further 
centrifugation (20000 x g, I h), the clear superna- 
tant was pumped at a flow rate of 0.5 ml/min onto 
8 Sep-Pak Cl8 cartridges (Waters Associates) con- 
nected in series. Bound material was eluted with 
aceto~trile/water/trifluoroacetic acid (80 : 19 : 1) 
and the effluent lyophilized. 
2.2. Purification of the peptides 
The intestinal extracts, after Sep-Pak concentra- 
tion, were redissolved in 1% (v/v) trifluoroacetic 
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acid (5 ml) and chromatographed at 4°C on a col- 
umn (100 x 2.6 cm) of Biogel P-10 (200-400 mesh) 
eluted at a flow rate of 20 ml/h with 0.2 M acetic 
acid. Fractions (3.8 ml) were assayed for substance 
P-like immunoreactivity (SP-LI) and neurokinin 
A-like immunoreactivity (NKA-LI) at appropriate 
dilution. The fractions with SP-LI and NKA-LI 
were separately pooled, lyophilized and redis- 
solved in 1% (v/v) trifluoroacetic acid (1 ml). 
After filtration (0.45 pm), the fractions were 
chromatographed on a semi-preparative Supelcosil 
LC-18-DB column (250x 10 mm) eluted at 30°C 
and at a flow rate of 2 ml/min with a linear 
gradient (120 ml) formed from acetonitrile/water/ 
trifluoroacetic acid (21 .O: 78.9 : 0.1) and acetoni- 
trile/water/trifluoroacetic acid (35 .O: 64.9 : 0.1). 
Absorbance was monitored at 214 and 280 nm and 
fractions (2 ml) assayed for SP-LI and NKA-LI. 
The peptide with SP-LI (scyliorhinin I) was puri- 
fied to homogeneity by chromatography under 
isocratic elution conditions on a Supelcosil LC-18- 
DB column (250 x 4.6 mm) ehtted at 30°C and at 
a flow rate of 1.5 ml/min with acetonitrole/water/ 
trifluoroacetic acid (25.2 :74.7 : 0.1). The peptide 
with NKA-LI (scyliorhinin II) was purified to 
homogeneity on the same column using acetoni- 
trile/water/trifluoroacetic acid (23.8 :76.1: 0.1) 
for isocratic elution. 
2.3. Structural analysis 
Amino acid composition was determined using a 
Durrum D-500 automatic analyser as described [7]. 
The primary structures of the peptides were deter- 
mined by automated Edman degradation using an 
Applied Biosystems model 470 A gas-phase se- 
quencer [8]. The detection limit for PTH-amino 
acids was 0.5 pmol. Scyliorhinin II was reduced 
and pyridylethylated according to [9]. 
2.4. Analytical methods 
SP-LI was measured by radioimmunoassay us- 
ing antiserum P4 that is directed towards the C- 
terminal region of substance P [4]. The antiserum 
shows approx. 35% cross-reactivity with physa- 
laemin, 14% with uperolein but less than 0.1% 
with the non-amidated form of substance P, its C- 
terminal methyl ester and with neurokinin A. SP- 
LI was also measured using antiserum R-140, 
directed against he N-terminal region of substance 
P, that shows full cross-reactivity with the non- 
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amidated form of substance P but no detectable 
cross-reactivity with other tachykinins [lo]. NKA- 
LI was measured using an antiserum directed 
against the C-terminal region of neurokinin A that 
reacts fully with neurokinin A (3-10) fragment but 
shows <O. 1% reactivity with neurokinin A (l-8) 
and only 0.4% cross-reactivity with substance P 
151. The ability of the tachykinins to contract the 
longitudinal muscle of the guinea pig ileum was 
determined as in [l I]. 
3. RESULTS 
3.1. Tachykinin-like immunoreactivity in 
gut extracts 
The initial extracts of dogfish gut contained im- 
munoreactivity equivalent o 64 pmol/g substance 
P measured with the C-terminally directed an- 
tiserum, no detectable immunoreactivity using the 
antiserum directed against the N-terminal region 
of substance P and immunoreactivity equivalent o 
61 pmol/g neurokinin A using the C-terminally 
directed antiserum to neurokinin A. From these 
results it is concluded that substance P identical to 
the mammalian sequence is absent from the dogfish 
gut. 
3.2. Purification of the peptides 
The elution profile on Biogel P-10 of the gut ex- 
tracts, after concentration on Sep-Pak cartridges, 
is shown in fig.1. The SP-LI was eluted from the 
column as a single peak with K,, between 0.73 and 
0.89. The NKA-LI was eluted as a single peak with 
K,, between 0.55 and 0.68 (chromatogram not 
shown). As shown in fig.2, the peptide with SP-LI 
(scyliorhinin I) was eluted from a semi-preparative 
reverse-phase HPLC column as a single peak with 
a retention time between 38 and 39 min (substance 
P: 45.4 min). The peak of immunoreactivity cor- 
responded to the peak of UV conditions of chro- 
matography, the peptide with NKA-LI (scyliorhi- 
nin II) was eluted as a single peak with a retention 
time between 36 and 37 min (neurokinin A: 34.2 
min) and the peak of immunoreactivity corre- 
sponded to a prominent peak of UV absorbance 
(fig.3). Under isocratic elution conditions 
(chromatograms not shown), scyliorhinin I was 
eluted as a single peak (retention time 15.8 min) 
that showed absorbance at 214 and 280 nm, indi- 
cating the presence of a tyrosine and/or trypto- 
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Fig.1. Elution profile on Biogel P-10 of the substance P- 
like immunoreactivity, measured with a C-terminally 
directed antiserum, in extracts of dogfish intestine. No 
detectable immunoreactivity was measured using an an- 
tiserum directed towards the N-terminal region of 
substance P. Neurokinin A-fike immunoreactivity was 
eiuted as single peak in fractions 93-104. VO and Vt refer 
to the void volume and total volume of the column and 
fractions denoted by the hatched bar were subjected to 
further purification by HPLC. 
NK.4 
L ‘; 
Fig.2. Reverse-phase HPLC on a semi-preparative col- 
umn of fractions from gel filtration containing sub- 
stance P-like immunoreactivity (SP-LI). Fractions de- 
noted by the hatched bar contained SP-LI and were fur- 
ther purified by HPLC under isocratic elution condi- 
tions. The arrows show the retention times of substance 
P and neurokinin A; (- --) concentration of acetoni- 
trile in the elution solvent. 
phan residue. The final yield of the peptide was 
approx. 3 nmol. Scyliorhinin II was eluted under 
isocratic conditions as a single peak with retention 
time 18.6 min and was devoid of absorbance at 280 
min. The final yield of peptide was approx. 
8 nmol. 
Fig.3. Reverse-phase HPLC on a semi-preparative col- 
umn of fractions from gel filtration containing neuro- 
kinin A-like immunoreactivity (NRA-LI). Fractions 
denoted by the hatched bar contained NRA-L1 and were 
further purified by HPLC under isocratic elution condi- 
tions. Conditions of chromatography were the same as 
in fig.2 and details are given in the text. 
3.3. Structural analysis 
The results of automated Edman degradation of 
scyliorhinin I and II (underivatized and pyridyl- 
ethylated peptide) are shown in table 1. Unam- 
biguous assignment of residues (I-10) of scyli- 
orhinin I was possible. The fall in yield of PTH- 
amino acids at cycle nos 9 and 10 suggests that the 
C-terminal methionine residue may be amidated as 
the Leu-Met-NH2 and Met-NH2 would tend to be 
washed out of the glass fibre disc of the sequencer 
during the last two degradation cycles. The amount 
of scyliorhinin I available was insufficient to per- 
mit confirmation of the sequence by determination 
of amino acid composition. Unambiguous assigna- 
tion of residues (1-17) of scyliorhinin II was possi- 
ble. The presence of cysteine residues at positions 
7 and 13 was demonstrated by subjecting the 4- 
vinylpyridine-derivatized peptide to Edman degra- 
dation. PTH-methionine was detected only in a 
trace amount at cycle 18 but the presence of a 
methionine residue in scyliorhinin II was confirmed 
by amino acid analysis. The composition of the 
peptide (Asx, 2.94; Ser, 2.66; Pro, 3.40; Gly, 2.28; 
Val, 0.99; Leu, 1.07; Phe, 0.85; Lys, 1.03; Met; 
0.27; Met(oxidized), 0.56) was consistent with the 
structure determined by Edman degradation but 
indicated that the methionine residue had been 
partially oxidized to the sulphoxide derivative 
during the purification. 
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Volume 200, number 1 FEBSLETTERS May 1986 
Table 1 
Automated Edman degradation of scyliorhinin I and II (underivatized and following 
pyridylethylation f cysteine residues) 
Cycle 
no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
Scyliorhinin I Scyliorhinin II Scyliorhinin II
(underivatized (vinylpyridine-treated 
peptide) peptide) 
PTH Yield PTH Yield PTH Yield 
amino @no11 amino (Pm011 amino (pmol) 
acid acid acid 
Ala 1584 Ser 429 Ser 455 
LYS 2187 Pro 2268 Pro 1122 
Phe 1648 Ser 203 Ser 216 
Asp 281 Asn 1991 Asn 1323 
LYS 1276 Ser 13.5 Ser 166 
Phe 1054 LYS 935 LYS 942 
TYr 824 PE-Cys 718 
Gly 902 Pro 984 Pro 836 
Leu 508 ASP 371 Asp 323 
Met 295 Gl 723 Y Gl Y 675 
Pro JO6 Pro 588 
Asp 289 Asp 242 
PE-Cys 385 
Phe 205 Phe 365 
Val 136 Vai 128 
Gly 109 Gly 77 
Leu 55 Leu 
(Met) trace (Met) Y6 
PE-Cys, 4-vinylpyridine derivative of cysteine 
3.3. Properties of the sc~iior~inin~ 
As shown in fig.4, serial dilution of purified 
scyliorhinin I inhibited the binding of ‘2SI-labelled 
[Tyr’]substance P to the C-terminally directed an- 
tibody but gave rise to a dilution slope that was not 
parallel to that produced by substance P. This 
result is consistent with the substitution Tyr for 
Phe at position 7 of scyliorhinin I and serial dilu- 
tions of physalaemin and uperolein also give rise to 
non-parallel dilution slopes in this radioimmuno- 
assay system. In contrast, serial dilution of puri- 
fied scyliorhi~n II diluted in parallel with neuro- 
kinin A using a C-terminally directed antiserum, 
consistent with the identity of the sequence Phe- 
Val-Gly-Leu-Met-NH2 in both peptides. 
Sufficient pure material was not available to 
compare the potencies of the scyliorhinins with the 
m~rn~ian ~chyki~ns but both scyliorhi~n I 
and II produced an immediate and dose-dependent 
contraction of the longitudinal muscle of the 
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guinea pig ileum. An amidated C-terminal residue 
in the tachykinins is an absolute requirement for 
contractile activity [12] so that the biological 
properties, as well as the immunochemical proper- 
ties, of the scyliorhinins strongly suggest hat the 
TabIe 2 
A comparison of the sequences of the scyliorhinins with 
tachykinins of amphibian and mammalian origin 
Scyliorhinin I AKFDKFYGLM 
Physalaemin EADPNKFYGLM 
Uperolein EPDPNAFYGLM 
Substance P RPKPQQFFGLM 
Scyliorhinin II 
SPSNSKCPDGPDCFVGLM 
GluZProS-Kassinin DVPKPDQFVGLM 
Neurok~in A HKTDSFVGLM 
Neurokinin B DMHDFFVGLM 
Kassinin DVPKSDQFVGLM 
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Fig.4. Immunochemical properties of (A) dogfish SP-LI (scyliorhinin I) (M) compared with substance P (X-X) 
in a radioimmunoassay using a C-terminally directed antiserum to substance P and (B) dogfish NRA-L1 (scyliorhinin 
II) (M) compared with neurokinin A (X-X) in a radioimmunoassay using a C-terminally directed antiserum to 
neurokinin A. Bsp represents total binding minus binding in the absence of antiserum. 
C-terminus of both peptides is amidated. Chemical 
confirmation of this fact is, however, still re- 
quired. 
4. DISCUSSION 
This report has demonstrated that the mam- 
malian peptides, substance P and neurokinin A, 
are absent from the gut of the common dogfish. 
The tissue contains, however, two novel peptides 
with tachykinin-like immunoreactivity and bioac- 
tivity. The structures of these peptides, scyliorhinin 
I and II, are compared with previously character- 
ized tachykinins in table 2. Maximum homology 
occurs between scyliorhinin I and the amphibian 
peptide, physalaemin (7 residues) and between 
scyliorhinin II and the peptide Glu2Pros-kassinin 
(7 residues), isolated from the skin of the African 
frog Hylambates maculatus [6]. S. caniculus, an 
elasmobranchian cartilaginous fish, diverged from 
the line of evolution leading to mammals approx. 
350 million years ago. If the scyliorhinins and the 
mammalian tachykinins are derived from the same 
ancestral tachykinin molecule, this study has 
demonstrated that evolutionary pressure has 
operated only to conserve the C-terminal regions 
of the molecules that are believed to interact with 
the tachykinin receptors [ 121. 
The presence of tachykinin-like immunoreactivi- 
ty in the gastointestinal tract and brain of fishes 
has been demonstrated previously. Consistent with 
the present report, extracts of the nervous system 
of skate and mackerel caused a displacement of 
radiolabelled substance P tracer from a C-termi- 
nally directed antibody that was not parallel to the 
substance P standard curve [ 131. Using immuno- 
histochemical techniques, the presence of a sub- 
stance P-related antigen was demonstrated in 
nerves of the gut wall of the spiny dogfish, Squalus 
acanthias [14] and in cells of the mid-gut epi- 
thelium of the teleostean fish, Pelmatochromis 
p&her [ 151. The sequence Phe-X-Gly-Leu-Met- 
NH2 is, however, phylogenetically much older than 
the fishes. Substance P-like immunoreactivity has 
been detected in the neural ganglion of the sea 
squirt, Ciona intestinalis (a Urochordate) [16], in 
nerve cells within the basal disk and tentacles of 
the Hydra (a coelenterate) [17] and in a giant 
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neuron of the garden snail, Helix aspersa (a mol- 
lust) [18]. The gut and brain of the Atlantic hag- 
fish, Myxine gi~~i~osa (a cyclostome), contains 
both SP-LI and NKA-LI in molecular forms that 
are distinct from the mammalian peptides (J.M. 
Conlon and S. Falkmer, unpublished). 
In bovine brain, the syntheses of substance P 
and neurokinin A are directed by the same mRNA 
[Is] and co-localization of the peptides in a popu- 
lation of rat primary sensory neurones has been 
demonstrated [20]. It is not possible on the basis of 
this study to conclude that scyliorhinin I and II are 
derived from the same biosynthetic precursor. Fur- 
ther immunohistochemical work is underway, 
however, to determine whether the peptides are 
localised in the same or different populations of 
nerves. 
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